Dublin, March 05, 2026 (GLOBE NEWSWIRE) — The “Elastomeric Infusion Pumps Market by Type, Application, End-use Industry, and Region – Global Forecast to 2030” has been added to ResearchAndMarkets.com’s offering.
The elastomeric infusion pumps market is anticipated to grow from USD 1.15 billion in 2025 to USD 1.49 billion by 2030, marking a CAGR of 5.3% during the forecast period. Driven by demands in oncology, pain management, anesthesia, and home care, these non-electronic devices facilitate outpatient care by providing reliable, continuous drug delivery without complex circuitry.
Regulations from the EMA and FDA are prompting manufacturers to enhance safety and quality standards, leading to innovations like multi-chamber designs and improved elastomers. Efforts to reduce medical waste are seen in real-time dosage monitoring and the integration of eco-friendly materials.
Pain Management Dominates the Market in 2024
As the largest segment for elastomeric infusion pumps in 2024, pain management reflects their widespread adaptation for surgical and chronic pain treatments. These pumps ensure efficient analgesic delivery, minimizing hospital stays and improving patient mobility.
Hospitals Lead the Market Share in 2024
Within hospitals, these pumps are crucial for delivering unrelenting medication in postoperative, chemotherapy, and other settings, independent of electronic components. Their design aligns with infection control standards and reduces cross-contamination risks, supporting their hospital prevalence.
North America Heads the Regional Market in 2024
The region’s advanced healthcare infrastructure, coupled with a high incidence of chronic diseases, underpins its market dominance. Reimbursement policies and trends in outpatient services heavily fuel the adaptation of patient-friendly infusion systems.
Key companies include Baxter (US), B. Braun SE (Germany), NIPRO (Japan), AVNS (US), Vygon (France), WOOYOUNG MEDICAL CO., LTD. (South Korea), Shanghai INT Medical Instruments Co., Ltd. (China), Ambu A/S (Denmark), Palex (Spain), and DAIKEN MEDICAL CO., LTD. (Japan).
This comprehensive analysis offers insights into market drivers, opportunities, and restraints impacting the elastomeric infusion pumps market. The report provides vital competitive intelligence and strategic insights into market leaders, enabling stakeholders to craft effective go-to-market strategies.
- Drivers include the rising prevalence of chronic diseases and a shift to home-based care.
- Restraints encompass performance variability and stringent regulatory compliance.
- Opportunities lie in emerging market advancements and specialization for complex medications.
- Challenges involve competing electronic technologies and precision maintenance in production.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 242 |
| Forecast Period | 2025 – 2030 |
| Estimated Market Value (USD) in 2025 | $1.15 Billion |
| Forecasted Market Value (USD) by 2030 | $1.49 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
Market Dynamics
Drivers
- Rising Prevalence of Chronic Diseases
- Growing Shift to Ambulatory and Home-based Care
- Disposable and Portable Design
Challenges
- Intense Competition with Electronic Infusion Technologies
- Maintaining Precision and Safety in Scaled Elastomeric Pump Production
Opportunities
- Rising Healthcare Advancements in Emerging Economies
- Specialization for High-Viscosity Drugs and Biologics
Industry Trends
- Strategic Moves by Tier-1/2/3 Players
Case Studies
- Mobility Enhancement in Infusion Therapy Using Surefuser+ Pump
- Cost-Saving Potential of Elastomeric Pumps in Postoperative Pain Therapy
- Improved Quality of Life in Chemotherapy with Surefuser+ Pump
Company Profiles
- Baxter
- B. Braun SE
- Nipro
- Avns
- Vygon
- Wooyoung Medical Co. Ltd.
- Shanghai Int Medical Instruments Co. Ltd.
- Ambu A/S
- Palex
- Daiken Medical Co. Ltd.
- Promecon GmbH
- S&S Med
- Epic Medical
- Multimedical S.R.L.
- Tecnoline S.P.A.
- Zhejiang Fert Medical Device Co. Ltd.
- Ace Medical
- Gamastech Srl
- First Medical Source
- Deltamed
- Vikymed Italia Srl
- Changzhou Medical Bioengineering Co. Ltd.
- Mais India
- Narang Medical Limited
- Zebra Medical
For more information about this report visit https://www.researchandmarkets.com/r/46djzn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Elastomeric Infusion Pumps Market
